Advertisement
Daxor Corporation

Daxor Corporation (DXR) Stock Overview

Explore Daxor Corporation’s financial performance, market position, analyst ratings, and future outlook.

DXRNASDAQ
HealthcareMedical - Instruments & Supplies
$10.00
$0.10(0.99%)
U.S. Market opens in 9h 48m
Advertisement

Daxor Corporation (DXR)

Meyka AI Score

Z

Key Financials

Market Cap51M
P/E Ratio5.42
EPS (TTM)$1.64
ROE0.22%
Fundamental Analysis

AI Price Forecasts

1 Month$9.28
3 Months$12.96
1 Year Target$16.49

DXR Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Daxor Corporation (DXR) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 45.66, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $16.49.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 5.42 and a market capitalization of 51M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-1.58%
5-Day Change
-3.12%
1-Month Change
-0.10%
3-Month Change
-12.04%
6-Month Change
-20.48%
Year-to-Date (YTD) Change
-32.61%
1-Year Change
7.46%
3-Year Change
2.79%
5-Year Change
-24.64%
All-Time (Max) Change
4.63%

Contact Information

12123308500
109 Meco Lane, Oak Ridge, TN, 37830

Company Facts

37 Employees
IPO DateJul 25, 1983
CountryUS
Actively Trading

Frequently Asked Questions